ResearcherUniversity of Southern CaliforniaNo recent work listed

Kai Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8647-1182; OpenAlex author ID A5100437988. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. Last author DOI 10.1007/s00726-018-2566-y ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Zhang · 1 shared paper, 2018 · strength 0.10
- Paper PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. DOI 10.1007/s00726-018-2566-y ↗
Xiaohui Wang · 1 shared paper, 2018 · strength 0.10
- Paper PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. DOI 10.1007/s00726-018-2566-y ↗
Yumin Li · 1 shared paper, 2018 · strength 0.10
- Paper PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. DOI 10.1007/s00726-018-2566-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.